Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes

Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway

(2020) Rosalinda Madonna et al.   Journal of Clinical Medicine

Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism

(2020) Rosalinda Madonna et al.   VASCULAR PHARMACOLOGY

Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo

(2018) Yue Guo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling

(2018) Joshua Mayourian et al.   CIRCULATION RESEARCH

Therapeutic benefits of CD90-negative cardiac stromal cells in rats with a 30-day chronic infarct

(2018) Deliang Shen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

European Society of Cardiology: Cardiovascular Disease Statistics 2017

(2017) et al.   EUROPEAN HEART JOURNAL

The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration

(2017) Chiara Cencioni et al.   PHARMACOLOGY & THERAPEUTICS

Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects

(2017) Ioanna Andreadou et al.   Frontiers in Physiology

NA+/H+ Exchanger 1-and Aquaporin-1-Dependent Hyperosmolarity Changes Decrease Nitric Oxide Production and Induce VCAM-1 Expression in Endothelial Cells Exposed to High Glucose

(2017) R. Madonna et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome

(2016) Hiroaki Kusaka et al.   Cardiovascular Diabetology

Where frailty meets diabetes

(2016) Stany Perkisas et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: As biomarkers and targets for new treatments

(2016) Rosalinda Madonna et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis

(2015) Rosalinda Madonna et al.   CURRENT DRUG TARGETS

Cardiac fibroblasts: from development to heart failure

(2015) Thomas Moore-Morris et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

High glucose induces human endothelial dysfunction through an Axl-dependent mechanism

(2014) Chien-Hsing Lee et al.   Cardiovascular Diabetology

Preparing the ground for tissue regeneration: from mechanism to therapy

(2014) Stuart J Forbes et al.   NATURE MEDICINE

Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart

(2014) Ivana Vrhovac et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE

(2013) C. Penna et al.   BASIC RESEARCH IN CARDIOLOGY

Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair

(2013) Mei Xin et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Sodium–hydrogen exchangers (NHE) in human cardiovascular diseases: Interfering strategies and their therapeutic applications

(2013) Rosalinda Madonna et al.   VASCULAR PHARMACOLOGY

Diabetes and Aging: Epidemiologic Overview

(2008) John E. Morley   CLINICS IN GERIATRIC MEDICINE